|
Creaspine's SupStance™ PEEK VBR gains FDA approval
Bordeaux, January 4, 2008 / Creaspine SAS / -- Bordeaux-based Creaspine SAS, a research and innovation start-up and manufacturer of spinal implant devices, has received on December 18, 2007 approval from the FDA to market the new PEEK-Optima® tumor and trauma VBR system.
'We are pleased to bring this new technology to the US market', declared Franck Tricot, Creaspine's Director of Business Development. “Our goal was to develop a real distraction solution that would help surgeons to be effective in achieving their surgical objectives when completing a VBR procedure”.
The SupStance™ PEEK VBR system will be distributed exclusively in the US by Saint-Louis, Missouri-based SpineSource, Inc.
Publisher Contact Information:
Creaspine SAS
+33 557 102 854
franck.tricot@creaspine.comCompany profile of Creaspine SAS
Past press releases of Creaspine SAS.
| | Data
27,722
Tech investments
From our Online Data Service
|
17,881
VC-backed companies
From our Radar
|
Recent Deals
For information on Europe's most extensive database on technology funding click here!
|  |
Events
Press Releases
|
